نتائج البحث - Katherine I. Lin

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

    The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course حسب Constantine S. Tam, Lynne V. Abruzzo, Katherine I. Lin, Jorge E. Cortés, Alice Lynn, Michael J. Keating, Deborah A. Thomas, Sherry Pierce, Hagop M. Kantarjian, Srđan Verstovšek

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells

    Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells حسب Shilpee Dutt, Anupama Narla, Katherine I. Lin, Ann Mullally, Nirmalee Abayasekara, Christine Megerdichian, Frederick H. Wilson, Treeve Currie, Arati Khanna‐Gupta, Nancy Berliner, Jeffery L. Kutok, Benjamin L. Ebert

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Acoustic separation and concentration of exosomes for nucleotide detection: ASCENDx

    Acoustic separation and concentration of exosomes for nucleotide detection: ASCENDx حسب Ty Naquin, Aidan J. Canning, Yuyang Gu, Jianing Chen, Chloe M. Naquin, Jianping Xia, Brandon Lu, Shujie Yang, Aleksandra Koroza, Katherine I. Lin, Hsin‐Neng Wang, William R. Jeck, Luke P. Lee, Tuan Vo‐Dinh, Tony Jun Huang

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens

    Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related... حسب Katherine I. Lin, Constantine S. Tam, Michael J. Keating, William G. Wierda, Susan O’Brien, Susan Lerner, Kevin R. Coombes, Ellen Schlette, Alessandra Ferrajoli, Lynn L. Barron, Thomas J. Kipps, Laura Z. Rassenti, Stefan Faderl, Hagop M. Kantarjian, Lynne V. Abruzzo

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease

    Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease حسب James E. Bradner, Raymond H. Mak, Shyam K. Tanguturi, Ralph Mazitschek, Stephen J. Haggarty, Kenneth N. Ross, Cindy Chang, Jocelyn Bosco, Nathan West, Elizabeth M. Morse, Katherine I. Lin, John Paul Shen, Nicholas Kwiatkowski, Nele Gheldof, Job Dekker, Daniel J. DeAngelo, Steven A. Carr, Stuart L. Schreiber, Todd R. Golub, Benjamin L. Ebert

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: